WHO-NNB is formed – to help accelerate access to vaccines

On May 27, 2016 the WHO-National Control Laboratory Network for Biologicals (WHO-NNB) was formed. This organisation “brings together national control laboratories and NRAs of vaccine-producing and vaccine recipient countries, WHO contract laboratories, manufacturer’s associations, WHO regional officers and other stakeholders, including donor. WHO-NNB ensures effective use of global resources by providing a platform and infrastructure for collaboration and exchange of information on quality and technical aspecst. It’s main objective is to facilitate access to and the availability of prequalified vaccines (and other biotherapeutic products) through reliance on batch releases by NRAs and national control laboratories that are members of WHO-NNB, thereby reducing redundant testing and encouraging more cost-effective testing and more effective regulatory oversight” [1]

• October 10, 2016  – “Terms of Reference for the first WHO-RIVM Global Vaccine Quality Control Laboratories Networking Meeting  – Building confidence in prequalified vaccines — Accelerated access to vaccines“,
• December 15, 2017 – First general meeting of WHO-NNB – BACKGROUND, REPORT
• WHO do not report any meeting between 2019 (3rd) and 2024 (5th) – HERE